Minnow Medical Secures $4.7M Via Equity and Convertible Debt Financing
Minnow Medical Inc. completed two separate funding transactions. The Laguna Hills, Calif.-based developer of a treatment for in-stent restenosis and other peripheral vascular conditions obtained a total of $4.7 million. It sold $3.2 million in preferred shares and $1.5 million in convertible notes that may be exchanged for into preferred stock. Neomed Management was the lead investor in both deals. Minnow’s Chairman Olav Bergheim, Christopher Weil & Co. and other private investors participated in the financing.
21 October 2010•3 mins read
